Androgen receptor (AR) down regulation by locked nucleic acid antisense oligonucleotides specifically inhibits the growth of AR-positive tumor cells

被引：0
|
作者：
Liao, Baisong [1 ]
Zhang, Yixian [1 ]
Kosek, Jolanta [1 ]
Liu, Wenzhe [1 ]
Castaneda, Stephen [1 ]
Greenberger, Lee [1 ]
Horak, Ivan [1 ]
机构：
[1] ENZON Pharmaceut Inc, Piscataway, NJ USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4631
引用
收藏
页数：1
相关论文
共 23 条
  • [1] A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro tumor growth in vivo
    Zhao, Lijie
    Han, Xin
    Lu, Jianfeng
    McEachern, Donna
    Wang, Shaomeng
    NEOPLASIA, 2020, 22 (10): : 522 - 532
  • [2] EFFECT OF ANDROGENS AND THEIR MANIPULATION ON CELL-GROWTH AND ANDROGEN RECEPTOR (AR) LEVELS IN AR-POSITIVE AND AR-NEGATIVE HUMAN HEPATOCELLULAR CARCINOMAS
    YU, LQ
    NAGASUE, N
    MAKINO, Y
    NAKAMURA, T
    JOURNAL OF HEPATOLOGY, 1995, 22 (03) : 295 - 302
  • [3] In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides
    Fluiter, K
    ten Asbroek, ALMA
    de Wissel, MB
    Jakobs, ME
    Wissenbach, M
    Olsson, H
    Olsen, O
    Oerum, H
    Baas, F
    NUCLEIC ACIDS RESEARCH, 2003, 31 (03) : 953 - 962
  • [4] Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells
    Wang, Li
    Gong, Shuaishuai
    Zhang, Xi
    Azhar, Zeb
    Chen, Jialin
    GENE, 2023, 866
  • [5] Down regulation of beta-catenin by a locked nucleic acid oligonucleotide antagonist inhibits tumor growth in experimental models of human cancer
    Dumble, M.
    Zhang, Y.
    Zhu, P.
    Kim, S.
    Qu, Z.
    Shi, V.
    Kearney, J.
    Greenberger, L. M.
    Horak, I. D.
    EJC SUPPLEMENTS, 2010, 8 (07): : 26 - 26
  • [6] Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
    Michmerhuizen, Anna R.
    Chandler, Benjamin
    Olsen, Eric
    Wilder-Romans, Kari
    Moubadder, Leah
    Liu, Meilan
    Pesch, Andrea M.
    Zhang, Amanda
    Ritter, Cassandra
    Ward, S. Tanner
    Santola, Alyssa
    Nyati, Shyam
    Rae, James M.
    Hayes, Daniel
    Feng, Felix Y.
    Spratt, Daniel
    Wahl, Daniel
    Eisner, Joel
    Pierce, Lori J.
    Speers, Corey
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [7] Down-modulation of the androgen receptor (AR) with EZN-4176 inhibits the growth of prostate tumor and potentiates the inhibitory effect of MDV-3100, a novel anti-androgen
    Zhang, Y.
    Castaneda, S.
    Kim, S.
    Qu, Z.
    Kraft, P.
    Wang, M.
    Dumble, M.
    Zhao, H.
    Greenberger, L.
    Horak, I.
    EJC SUPPLEMENTS, 2010, 8 (07): : 71 - 72
  • [8] Down-Modulation of Survivin Expression and Inhibition of Tumor Growth In Vivo by EZN-3042, A Locked Nucleic Acid Antisense Oligonucleotide
    Sapra, Puja
    Wang, Maoliang
    Bandaru, Raj
    Zhao, Hong
    Greenberger, Lee M.
    Horak, Ivan D.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2010, 29 (02): : 97 - 112
  • [9] A novel dual lock method for down-regulation of genes, in which a target mRNA is captured at 2 independent positions by linked locked nucleic acid antisense oligonucleotides
    Takata, Ryohei
    Makado, Gouki
    Kitamura, Ayaka
    Watanabe, Hajime
    Wada, Tadashi
    RNA BIOLOGY, 2016, 13 (03) : 279 - 289
  • [10] Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
    Pizon, Monika
    Lux, Daniel
    Pachmann, Ulrich
    Pachmann, Katharina
    Schott, Dorothea
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
123